Figure 8 Surgical

Palo Alto, United States Founded: 2009 • Age: 17 yrs
Offers a sternal closure system designed for open-heart surgery patients.

About Figure 8 Surgical

Figure 8 Surgical is a company based in Palo Alto (United States) founded in 2009. It operates as a B2B. Figure 8 Surgical has raised $43.1 million across 4 funding rounds from investors including Elizabeth Street, Maywic Select Investments and OCV Partners. Figure 8 Surgical operates in a competitive market with competitors including TISSIUM, Laminate Medical, Vivasure Medical, Cardival Medical and Saranas, among others.

Key Metrics
  • Total Equity Funding
    $43.1M (USD)

    in 4 rounds

  • Latest Funding Round
    $40M (USD), Series A

    Aug 2019

  • Investors

Funding Insights of Figure 8 Surgical

Figure 8 Surgical has successfully raised a total of $43.1M across 4 strategic funding rounds. The most recent funding activity was a Series A round of $40 million completed in August 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $43.1M
  • Total Rounds 4
  • Last Round Series A β€” $40M
  • First Round $1.36M

    (Jun 2010)

  • Investors Count 3

All 4 funding rounds of Figure 8 Surgical with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Aug 2019$40MSeries A–Elizabeth Street, Maywic Select Investments
Sep 2013$1.24MSeed––
–
Jun 2011$499,999Seed––
–
Jun 2010$1.36MSeed––
–
Valuation history

3 investors in total: 3 institutional.

Investors in Figure 8 Surgical

Figure 8 Surgical has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include Elizabeth Street, Maywic Select Investments and OCV Partners.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
Early-stage venture capital is invested in consumer sector startups.
–elizabethstreet.vcNew York, United States
Tech and offline focused venture capital firm investing primarily in the US
–maywic.comCincinnati, United States
Venture capital investments are provided by OCV Partners.
–ocvpartners.comLos Angeles, United States
Premium access

Investor details for Figure 8 Surgical

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of Figure 8 Surgical

3 dated milestones of Figure 8 Surgical across 10 years, from founding to its latest funding, stage changes and deals.

  1. Founded Figure 8 Surgical is founded.
  2. Funding First funding round of $1.4M.
  3. Funding Latest funding round, Series A, of $40.0M.

Competitors of Figure 8 Surgical

Figure 8 Surgical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as TISSIUM, Laminate Medical, Vivasure Medical, Cardival Medical and Saranas, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
tissium.com2013Paris, France$155.98M–
Vascular sealants for open surgery are developed by TISSIUM.
laminatemedical.com2012Rehovot, Israel$20M–
AV fistula maturation and patency are supported by VasQ device.
vivasuremedical.com2009Galway, Ireland$92.08M–
Bioabsorbable implants and delivery systems for arteriotomy closure are developed.
cardivamedical.com2002Santa Clara, United States$169.45M158
A device for vascular access management is developed.
saranas.com2011Houston, United States$29.46M–
A device is developed for detecting internal bleeding during catheterization.
aziyo.com2015Silver Spring, United States$49.59M162
Regenerative medicine products are developed for orthopedic and cardiovascular applications.
cordis.com1957Fremont, United States–5
Cardiovascular and endovascular devices are developed and marketed by Cordis.
innavasc.com2013Durham, United States$3.34M–
Synthetic vascular grafts with self-sealing chambers for hemodialysis are developed.
ekoscorp.com1995Bothell, United States$58.8M–
Ultrasound thrombolytic devices for pulmonary embolism treatment are developed.
Premium access

Detailed competitors of Figure 8 Surgical

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Figure 8 Surgical

Premium access

Complete news archive for Figure 8 Surgical

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Similar companies to Figure 8 Surgical

10 companies that operate in the same segment as Figure 8 Surgical (Cardiac and Vascular Disorders), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Connected devices for health, sleep, and activity monitoring are developed.
2008Moulineaux, Seine-maritime, FranceUSD 93.83 M––
SMT is recognized as a developer of cardiovascular medical devices.
1998Surat, Gujarat, IndiaUSD 57.22 MUSD 106.25 M1,090
Gene-editing therapies for coronary artery disease are developed.
2018Cambridge, Massachusetts, United StatesUSD 215.5 M–255
Cardiac monitoring devices and applications are provided for heart health.
2010Mountain View, California, United StatesUSD 114.38 MUSD 6.18 M67
Therapies for lowering low-density lipoprotein cholesterol levels are developed.
1998Ann Arbor, Michigan, United StatesUSD 129.7 MUSD 332.31 M304
Cloud-based ambulatory ECG monitors for cardiac arrhythmia diagnosis are provided.
2006San Francisco, California, United StatesUSD 109.23 MUSD 747.14 M2,000
Provider of neuroprotection devices for carotid artery disease
2007Sunnyvale, California, United StatesUSD 241.8 M––
Miniaturized wireless implantable sensors are developed for hemodynamic monitoring.
2007East Peoria, Illinois, United StatesUSD 154.77 M–104
Access catheters for neurovascular stroke treatment are provided.
2015Campbell, California, United StatesUSD 596 M––
Biosensor patches are developed for monitoring multiple body vitals.
2011Campbell, California, United StatesUSD 239.95 M–184
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Figure 8 Surgical

Figure 8 Surgical was founded in 2009 and raised its 1st funding round 1 year after it was founded.

Figure 8 Surgical is headquartered in Palo Alto, United States. It is registered at Palo Alto, California, United States.

Figure 8 Surgical is a funded company, having raised a total of $43.1M across 4 funding rounds to date. The company's 1st funding round was a Seed of $1.36M, raised on Jun 2010.

Figure 8 Surgical, established in 2009 and currently in Dissolved stage, focuses on providing healthcare solutions, developing medical devices, surgical equipment, and cardiac solutions. Offers a sternal closure system designed for open-heart surgery patients. Adapting to market demands with innovation and client-focused strategies.

Figure 8 Surgical's top competitors include TISSIUM, Vivasure Medical and Cardival Medical.

Figure 8 Surgical has 3 investors. Key investors include Elizabeth Street, Maywic Select Investments, and OCV Partners.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available